Industry News

Breaking Down the Cost of Sickle Cell Disease Gene Therapies

February 2, 2024 - Earlier this week, the Biden–Harris administration announced its plans to address the expensive price tag of sickle cell disease, looking for a way to widen access despite the cost. In an announcement by the United States Centers for Medicare and Medicaid Services (CMS), the organization noted that sickle cell disease will be the first focus...

Read More


Articles

Novo Nordisk Launches Vaccine Initiative for Airborne Infections

by

In an announcement published on December 18, 2023, Novo Nordisk, headquartered in Copenhagen, Denmark, announced its plans to allocate $260 million to research and develop vaccines for airborne...

Researcher Study Non-Opioid Pain Medication for Diabetic Neuropathy

by

On the tail of their win as the first FDA-approved CRISPR-based gene editing therapy, Vertex Pharmaceuticals announced the results of a phase 2 clinical trial for VX-548, a non-opioid pain management...

Antifungal Therapeutic Drug Monitoring Are Rates Lower Than Use Rates

by

According to the results of an article published in Open Forum Infectious Diseases, infectious disease specialists are not monitoring antifungal prescriptions at the same rates they are prescribing...

How New Platforms Are Saving Patients $4 Billion on Prescription Drugs

by

Today, Visory Health announced that it is ranked the fourth-largest prescription discount card in the United States, based on an analysis from IQVIA. The company revealed that it has saved 3.25 million...

Pfizer Sues Dexcel Pharmaceuticals Alleging Patent Infringement

by

Early this week, Pfizer and the Scripps Research Institute announced that they would be suing Israel’s Dexcel Pharma for patent infringement affecting Vyndamax, a drug that already generated $818...

Nektar Sues Eli Lilly for Incorrect Clinical Trial Results

by

On Monday, Nektar Therapeutics released a scathing public statement that accused its former partner, Eli Lilly, of miscalculating and sharing clinical trial results that underrepresented the...

New Reagent Delivers Biomolecules to Lung Tissue to Treat Lung Disease

by

On August 2, 2023, Altogen Biosystems announced and launched a new targeted reagent that can deliver biomolecules to the lungs, treating pulmonary diseases. According to the announcement, the drug has...

Comparing Merck and Pfizer’s 2022 ESG Ratings

by

Environmental, social, and governance assessments, commonly called ESG scores, are emerging metrics that are beginning to shape how pharmaceutical companies do business. MSCI Inc., an American finance...

Mallinckrodt Shareholders Doubt Company Will Pay $200M Opioid Settlement

by

United Kingdom-based Mallinckrodt is considering repeat bankruptcy as its $200 million opioid payment comes due. A Security and Exchange Commission (SEC) filing from June 5 showed that company...

How Do NIH Funding Requirements Impact Researcher Demographics?

by

An analysis of the impact of the National Institutes of Health (NIH) funding requirements determined that they improve diversity in medical scientist training programs (MSTPs). The data revealed more...

HHS Relaunched Health Sector Climate Pledge

by

In March 2023, the United States HHS announced plans to relaunch the Health Sector Climate Pledge, proposed by the White House in 2022. According to the press release, the healthcare sector accounts...

Meteoric Rise of Weight-Loss Drug Wegovy Brings Pushback to Novo Nordisk

by

In June of 2021, the FDA approved Novo Nordisk’s Wegovy to aid in weight management in overweight adults with weight-related chronic conditions like high blood pressure, type 2 diabetes, or high...

Looking for Solutions Amidst Pharmacist Shortages and Burnout

by

Recent commentary from CVS, Walgreens, Walmart, and other retail pharmacies has included discussions of shortened operation hours as a potential solution for the current pharmacist shortage and...

Takeda One Ups Pfizer, Moderna with 600,000 SF R&D Office in Cambridge

by

Kendall Square is a round table of the largest pharmaceutical companies in the world, and Tokyo-based Takeda will soon have a seat at that table with its massive new workspace. Takeda, the largest life...

FDA Awards 19 Grants for Rare Disease Research

by

On October 17, 2022, the FDA announced that its Orphan Products Grants Program has awarded 19 grants and 2 contracts, amounting to over $38 million, for rare disease research. This action will...

Kroger Health to End Express Scripts Pharmacy Provider Agreement

by

Last week, Kroger Health — the grocery store chain’s pharmacy business — surprised Express Scripts with written notice of intention to terminate their agreement for commercial...

Pharmaceutical Company Biogen to Pay $900M False Claims Act Settlement

by

Monday, Boston pharmaceutical company Biogen agreed to pay $900 million to settle a case where it was accused of offering illegal programs that induced physicians to prescribe the drugs Avonex,...

FDA Announces That 35% of Drug Samples Were Non-Compliant

by

The FDA’s Report on The State of Pharmaceutical Quality is published annually to analyze quality measures related to drug manufacturers and products. The report looked at manufacturing site...

Merck & Co Manufacturing Mishap Leads to Carcinogen in Diabetes Medication

by

Last week, Merck & Co made the FDA aware of the presence of nitrosamine in its type 2 diabetes drug, Januvia. Merck’s analysis of the drug found nitrosamine levels higher than allowed by the...

Recent Articles